4080-54-0

Basic information

• Product Name: 4-Pyridinecarboxylicacid,3-ethyl-(9CI)
• Synonyms: 4-Pyridinecarboxylicacid,3-ethyl-(9CI);4-Pyridinecarboxylic acid, 3-ethyl-;3-Ethyl-4-pyridine carboxylic acid;3-ethylpyridine-4-carboxylic acid
• CAS NO: 4080-54-0
• Molecular Formula: C₈H₉NO₂
• Molecular Weight: 151.16256
• Product Categories: CARBOXYLICACID
• Mol File: 4080-54-0.mol
• Article Data: 11

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 4-Pyridinecarboxylicacid,3-ethyl-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Pyridinecarboxylicacid,3-ethyl-(9CI)(4080-54-0)
• EPA Substance Registry System: 4-Pyridinecarboxylicacid,3-ethyl-(9CI)(4080-54-0)

Safety Data

• Hazardous Substances Data: 4080-54-0(Hazardous Substances Data)

Usage

General Description

4-Pyridinecarboxylicacid,3-ethyl-(9CI) is a chemical compound with the molecular formula C8H9NO2. Also known as ethyl nicotinate, it is a derivative of nicotinic acid and is commonly used in the synthesis of pharmaceuticals and agrochemicals. Ethyl nicotinate has been shown to have vasodilatory and anti-inflammatory properties, making it a potentially useful compound in the treatment of various medical conditions. It is also used as a flavoring agent in the food industry. However, ethyl nicotinate should be handled with caution, as it may cause skin and eye irritation and is harmful if swallowed or inhaled.

Upstream product

• 59786-31-1 methyl 3-bromoisonicotinate 
• 13341-16-7 methyl 3-ethyl-4-pyridinecarboxylate 
• 529-21-5 3-ethyl-4-methylpyridine 
• 536-78-7 3-ethylpyridine 
• 14906-62-8 3-ethylpyridine N-oxide 
• 13341-18-9 3-ethylpyridine-4-carbonitrile 

Downstream Products

• 1282541-15-4 3-ethyl isonicotinic acid chloride 
• 1192021-71-8 N-[4-chloro-2-hydroxy-5-(trifluoromethyl)phenyl]-3-ethyl isonicotinamide 
• 102235-18-7 3-ethyl-4-pyridinemethanol 

Relevant articles and documents

HETEROCYCLIC COMPOUNDS AND USES THEREOF

Provided herein are novel heterocyclic compounds, for example, compounds having Formula I, I-P, II, lI-P, or III. Also provided herein are pharmaceutical compositions comprising the compounds and methods of using the same, for example, in inhibiting aldehyde dehydrogenases and/or for treating various cancers, cancer metastasis, type 2 diabetes, pulmonary arterial hypertension (PAH) or neointimal hyperplasia (NIH).

NON-PEPTIDE OPIOID RECEPTOR MODULATORS

Non-peptide MOR opioid receptor modulators are provided. The compounds exhibit predominantly central activity and are used to treat e.g. opioid addiction. The compounds described herein are generally delivered (administered) in a pharmaceutical compositio

HARMFUL ARTHROPOD CONTROL COMPOSITION, AND FUSED HETEROCYCLIC COMPOUND

Disclosed is a harmful arthropod control composition comprising, as an active ingredient, a fused heterocyclic compound represented by formula (1) [wherein A1 and A2 independently represent a nitrogen atom or the like; R1 and R4 independently represent a halogen atom or the like; R2 and R3 independently represent a halogen atom or the like; R5 and R6 independently represent a linear C1-C6 hydrocarbon group which may be substituted, or the like (provided that both R5 and R6 cannot represent a hydrogen atom simultaneously); and n represents 0 or 1]. The harmful arthropod control composition has an excellent efficacy to control harmful arthropods.